Is GLP-1 receptor agonist therapy safe for patients with intraductal papillary mucinous neoplasm?. Swiss Medical Weekly, [S. l.], v. 155, n. 10, p. 4850, 2025. DOI: 10.57187/s.4850. Disponível em: https://smw.ch/index.php/smw/article/view/4850. Acesso em: 22 oct. 2025.